Pathway is currently pursuing TGA approval for AIDP ingredients Magtein, KoACT, and enVantec.
AIDP Inc. (City of Industry, CA) has hired Pathway International Pty Ltd. to distribute AIDP’s dietary supplement and nutrition branded ingredients in Australia and New Zealand. Pathway will exclusively distribute AIDP branded ingredients Magtein magnesium L-threonate for cognitive health; KoACT, a patented chelated compound of calcium and hydrolyzed collagen peptides for bone health; and enVantec microencapsulation technology.
Pathway is currently pursuing approval for all three ingredients from the Australia’s Therapeutic Goods Administration, AIDP said. “We’re on the doorstep of TGA approval for Magtein and enVantec and convinced these branded products will be well received in Australia and New Zealand,” said Kathy Lund, AIDP’s director of business development, in a press release.
“Pathway is positioned to undertake the required regulatory work for these ingredients and has a proven track record in this process. While we’re waiting for TGA approval, we have time to work with our customers in parallel with this process. Furthermore, future market launches will be planned to coincide with the final TGA approval,” added Wayne Coote, managing director for Pathway International Pty Ltd.
Lund continued, “Furthermore, while we can’t place a dollar amount on this expansion, according to a recent article in Australia’s Daily Telegraph, despite the impact of ongoing global uncertainty and uneven conditions across sectors, the International Monetary Fund expects the Australian economy will outpace all major advanced economies over the next two years, and forecasts growth of 3.0% in 2012 and 3.5% in 2013. So we think this is a good place for brand expansion.”